Skip to main content
. 2025 Jun 16;17(12):2006. doi: 10.3390/cancers17122006
PC Pancreatic cancer
SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2
COVID-19 Coronavirus disease 2019
IgG Immunoglobulin G
PS Performance status
CEA Carcinoembryonic antigen
CA19-9 Carbohydrate Antigen 19-9
IgG4-RD IgG4-related disease
ELISA Enzyme-linked immunosorbent assay
NLR Neutrophil-to-lymphocyte ratio
mGPS modified Glasgow prognostic score
PNI Prognostic Nutritional Index
CRP C-Reactive Protein
AUC Area Under the Curve.
ROC Receiver Operating Characteristic
OS Overall Survival